Rosuvastatin is a lipid-regulating drug that does not significantly harm diabetes, some diabetic patients taking this drug may cause an increase in glycosylated hemoglobin and fasting serum glucose levels, and blood glucose monitoring can be performed before and after the use of the drug. Rosuvastatin, can be used for the treatment of mixed dyslipidemia, primary hypercholesterolemia, but also for patients with pure familial hypercholesterolemia, as an adjunct to dietary control, exercise, weight loss and other measures. Usually Rosuvastatin has no significant harmful effects on diabetes. There are reports suggesting that the use of Rosuvastatin may be associated with elevated glycosylated hemoglobin and fasting serum glucose levels in patients with diabetes. Patients with diabetes may be monitored for blood glucose before and after use of the drug. Adverse reactions such as headache, dizziness, myalgia, constipation, nausea, and abdominal pain may also occur with Rosuvastatin. People who are allergic to any of the ingredients in Rosuvastatin, severe renal impairment, etc. should be prohibited from taking this drug. Patients are advised to take the medication in strict accordance with the doctor’s instructions and should not change the dose of the drug without authorization or abuse the drug privately.